Justice and Equity in Trials of Deep Brain Stimulation for the Treatment of Addiction and Overeating

REFERENCES

• Baltuch , G. H. and Stern , M. B. 2007 . Deep brain stimulation for Parkinson's disease , New York , NY : Informa Healthcare .
   Google Scholar
• Bell , E. , Maxwell , B. , Sadikot , A. , McAndrews , M. and Racine , E. 2010 . Hope and patients’ expectations in deep brain stimulation: Healthcare providers perspectives and approaches . Journal of Clinical Ethics , 21 : 113 – 125 .
   Google Scholar
• Carter , A. , Bell , E. , Racine , E. and Hall , W. 2011 . Ethical issues raised by proposals to treat addiction using deep brain stimulation . Neuroethics , 4 ( 2 ) : 129 – 142 .
   Web of Science ®Google Scholar
• Carter , A. and Hall , W. 2011 . Proposals to trial deep brain stimulation to treat addiction are premature . Addiction , 106 ( 2 ) : 235 – 237 .
   PubMed Web of Science ®Google Scholar
• Hall , W. and Carter , A. 2012 . Is deep brain stimulation for addiction an acceptable crime control measure? . Addiction , 107 ( 7 ) : 1360 – 1360 .
   PubMed Web of Science ®Google Scholar
• Kessler , R. C. , Chiu , W. T. , Demler , O. , Merikangas , K. R. and Walters , E. E. 2005 . Prevalence, severity, and comorbidity of 12-month DSM-IV disorders in the National Comorbidity Survey Replication . Archives of General Psychiatry , 62 ( 6 ) : 617 – 627 .
   PubMed Web of Science ®Google Scholar
• Krupitsky , E. , Nunes , E. V. Ling , W. 2011 . Injectable extended-release naltrexone for opioid dependence: a double-blind, placebo-controlled, multicentre randomised trial . Lancet , 377 ( 9776 ) : 1506 – 1513 .
   PubMed Web of Science ®Google Scholar
• Kunoe , N. , Lobmaier , P. Vederhus , J. K. 2009 . Naltrexone implants after in-patient treatment for opioid dependence: Randomised controlled trial . British Journal of Psychiatry , 194 ( 6 ) : 541 – 546 .
   PubMed Web of Science ®Google Scholar
• Ling , W. , Casadonte , P. Bigelow , G. 2010 . Buprenorphine implants for treatment of opioid dependence: A randomized controlled trial . Journal of the American Medical Association , 304 ( 14 ) : 1576 – 1583 .
   PubMed Web of Science ®Google Scholar
• Lobmaier , P. P. , Kunoe , N. , Gossop , M. and Waal , H. 2011 . Naltrexone depot formulations for opioid and alcohol dependence: A systematic review . CNS Neuroscience and Therapeutics , 17 ( 6 ) : 629 – 636 .
   PubMed Web of Science ®Google Scholar
• Pisapia , J. M. , Halpern , C. H. Muller , U. J. 2013 . Ethical considerations in deep brain stimulation for the treatment of addiction and overeating associated with obesity . AJOB Neuroscience , 4 ( 2 ) : 35 – 46 .
   Google Scholar
• Schuepbach , W. M. M. , Rau , J. Knudsen , K. 2013 . Neurostimulation for Parkinson's disease with early motor complications . New England Journal of Medicine , 368 ( 7 ) : 610 – 622 .
   PubMed Web of Science ®Google Scholar
• Stephens , J. H. , Halpern , C. H. Barrios , C. J. 2012 . Deep brain stimulation compared with methadone maintenance for the treatment of heroin dependence: A threshold and cost-effectiveness analysis . Addiction , 107 ( 3 ) : 624 – 634 .
   PubMed Web of Science ®Google Scholar
• Vos , T. , Carter , R. Barendregt , J. 2010 . Assessing Cost-effectiveness in Prevention: ACE–prevention September 2010 final report , Brisbane , , Australia : The University of Queensland .
   Google Scholar